ESR1 and breast carcinoma: Collectively, these results indicated that the combination of GTPs and SFN can induce functional ERα re-expression and re-sensitize ERα-negative breast cancer cells to available SERM, TAM, which could provide an extremely important clinical implication in potential application of combination of bioactive dietary supplements as a therapeutic strategy for hormonal refractory breast cancer.